• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROPORT ORTHOPEDICS INC. PROFEMUR MODULAR NECK; HIP COMPONENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROPORT ORTHOPEDICS INC. PROFEMUR MODULAR NECK; HIP COMPONENT Back to Search Results
Model Number PHAX12XX
Device Problem Break (1069)
Patient Problem Failure of Implant (1924)
Event Date 12/20/2018
Event Type  Injury  
Manufacturer Narrative
This event will be updated once the investigation is complete.Trends will be evaluated.
 
Event Description
Allegedly, the doctor noted a fracture of a modular neck of his hip prosthesis, a surgical revision was performed consisting of a change of the entire femoral implant.
 
Manufacturer Narrative
No further information was received for this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROFEMUR MODULAR NECK
Type of Device
HIP COMPONENT
Manufacturer (Section D)
MICROPORT ORTHOPEDICS INC.
5677 airline rd.
arlington TN 38002
MDR Report Key11358218
MDR Text Key232843414
Report Number3010536692-2021-00100
Device Sequence Number1
Product Code MRA
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 04/22/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Device Model NumberPHAX12XX
Device Catalogue NumberPHAX12XX
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date02/02/2021
Initial Date Manufacturer Received 02/02/2021
Initial Date FDA Received02/22/2021
Supplement Dates Manufacturer Received02/02/2021
Supplement Dates FDA Received04/22/2021
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age47 YR
-
-